ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 228 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q1 2023. The put-call ratio across all filers is 1.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $12 | -14.3% | 304 | 0.0% | 0.00% | – |
Q1 2024 | $14 | -12.5% | 304 | -9.5% | 0.00% | – |
Q4 2023 | $16 | +60.0% | 336 | +19.1% | 0.00% | – |
Q3 2023 | $10 | -23.1% | 282 | 0.0% | 0.00% | – |
Q2 2023 | $13 | +18.2% | 282 | 0.0% | 0.00% | – |
Q1 2023 | $11 | -15.4% | 282 | 0.0% | 0.00% | – |
Q4 2022 | $13 | -99.9% | 282 | +8.0% | 0.00% | – |
Q3 2022 | $11,000 | -31.2% | 261 | 0.0% | 0.00% | – |
Q2 2022 | $16,000 | +14.3% | 261 | +31.2% | 0.00% | – |
Q1 2022 | $14,000 | -17.6% | 199 | 0.0% | 0.00% | – |
Q4 2021 | $17,000 | -19.0% | 199 | -14.2% | 0.00% | – |
Q3 2021 | $21,000 | +61.5% | 232 | +74.4% | 0.00% | – |
Q2 2021 | $13,000 | -13.3% | 133 | 0.0% | 0.00% | – |
Q1 2021 | $15,000 | -11.8% | 133 | +7.3% | 0.00% | – |
Q4 2020 | $17,000 | -39.3% | 124 | -63.5% | 0.00% | – |
Q3 2020 | $28,000 | +100.0% | 340 | +4.3% | 0.00% | – |
Q2 2020 | $14,000 | 0.0% | 326 | 0.0% | 0.00% | – |
Q1 2020 | $14,000 | 0.0% | 326 | 0.0% | 0.00% | – |
Q4 2019 | $14,000 | -6.7% | 326 | -8.9% | 0.00% | – |
Q3 2019 | $15,000 | -34.8% | 358 | 0.0% | 0.00% | – |
Q2 2019 | $23,000 | -8.0% | 358 | 0.0% | 0.00% | – |
Q1 2019 | $25,000 | +127.3% | 358 | +37.7% | 0.00% | – |
Q4 2018 | $11,000 | -45.0% | 260 | 0.0% | 0.00% | – |
Q3 2018 | $20,000 | 0.0% | 260 | 0.0% | 0.00% | – |
Q2 2018 | $20,000 | +53.8% | 260 | 0.0% | 0.00% | – |
Q1 2018 | $13,000 | – | 260 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
First Light Asset Management, LLC | 217,459 | $24,760,000 | 1.64% |
Motley Fool Asset Management LLC | 152,326 | $17,344,000 | 1.25% |
Rock Springs Capital Management LP | 450,000 | $51,237,000 | 1.12% |
AtonRa Partners | 21,017 | $2,393,000 | 1.07% |
SECTORAL ASSET MANAGEMENT INC | 112,200 | $12,775,000 | 0.97% |
EMERALD ADVISERS, LLC | 228,368 | $26,002,000 | 0.94% |
EMERALD MUTUAL FUND ADVISERS TRUST | 239,023 | $27,215,000 | 0.90% |
FEDERATED HERMES, INC. | 3,912,408 | $445,467,000 | 0.86% |
HealthCor Management, L.P. | 207,610 | $23,638,000 | 0.84% |
Atika Capital Management LLC | 66,000 | $7,515,000 | 0.65% |